Lactobacillus Reuteri in the Supportive Therapy of Periodontitis

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

February 12, 2024

Study Completion Date

June 12, 2024

Conditions

Periodontal Diseases

Interventions

DIETARY_SUPPLEMENT

Probiotic: Lactobacillus Reuteri

Lactobacillus reuteri ATCC PTA 5289 (a minimum of 2 × 108 colony-forming units L. reuteri Prodentis/lozenge, BioGaia AB)

DIETARY_SUPPLEMENT

Placebo

Placebo lozenge. Will be identical in taste, texture and appearance to the Probiotic one.

Trial Locations (1)

Magda Mensi, Brescia

All Listed Sponsors

lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

NCT04478643 - Lactobacillus Reuteri in the Supportive Therapy of Periodontitis | Biotech Hunter | Biotech Hunter